The addition of human recombinant soluble ACE2 reduced viral infection of kidney organoids and blocked early stages of infection, demonstrating the importance of ACE2 for infection of SARS-CoV-2 (Monteil et al. 2020; Wysocki et al. 2021). Here, ACE2 is linked to viral infectious disease.